drugset / Trial / NCT03450629

Evaluation of Safety and Efficacy of PDP-716

NCT03450629

Phase 3 Completed 682 enrolled Sun Pharma Advanced Research Company Limited
RandomizedParallel-groupSingle-blindTreatment

Summary

The study will be conducted to evaluate the efficacy and safety of topical administration of PDP-716 compared with brimonidine tartrate ophthalmic solution.

Timeline

Start
2018-09-13
Primary completion
2020-12-01
Completion
2020-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Brimonidine Small molecule Topical